Results 151 to 160 of about 161,781 (188)

Discovery of novel pyrimidine-based benzothiazole derivatives as potent cyclin-dependent kinase 2 inhibitors with anticancer activity

, 2019
Peng-Cheng Diao, Wei-Yuan Lin, Xie‐Er Jian, Yanhong Li, Wen‐Wei You, Pei‐Liang Zhao   +5 more
openalex   +1 more source

Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression. [PDF]

Oncotarget, 2015
Yang L, Fang D, Chen H, Lu Y, Dong Z, Ding HF, Jing Q, Su SB, Huang S.   +8 more
europepmc   +1 more source

Indole-3-Carbinol (I3C) Inhibits Cyclin-dependent Kinase-2 Function in Human Breast Cancer Cells by Regulating the Size Distribution, Associated Cyclin E Forms, and Subcellular Localization of the CDK2 Protein Complex

, 2004
Hanh H. Garcia, Gloria A. Brar, David H.H. Nguyen, Leonard F. Bjeldanes, Gary L. Firestone   +4 more
openalex   +1 more source

PTPN18 functions as a tumor suppressor in breast cancer by negatively regulating cyclin E. [PDF]

Int J Oncol
Zhang N, Wang T, Bai B, Zhang X, Xu W, Chen W, Yu Y, Wang B.   +7 more
europepmc   +1 more source

Combination of cyclin-dependent kinase 4/6 inhibitors and renin-angiotensin system inhibitors in breast cancer treatment: a promising therapeutic approach. [PDF]

Rev Assoc Med Bras (1992)
Mutlu E, İnanç M.
europepmc   +1 more source

Slowing the growth of drug-resistant tumors. [PDF]

Elife
Zhang Y, Lu Q.
europepmc   +1 more source

Engineering Immortalized Bovine Granulosa Cells Using a Triple-Gene Approach: Mutant CDK4, Cyclin D1, and TERT. [PDF]

Cell Biol Int
Bai L, Takahashi M, Kobayashi J, Eitsuka T, Matsusaka H, Ozaki T, Sugano E, Tomita H, Xu Y, Kawamura K, Nakagawa K, Kiyono T, Fukuda T.   +12 more
europepmc   +1 more source

Analysis of Breast Cancer Brain Metastases Reveals an Enrichment of Cyclin-Dependent Kinase 12 Structural Rearrangements in Human Epidermal Growth Factor Receptor 2–Positive Disease

Talvinder Bhogal, Athina Giannoudis, Ethan S. Sokol, Simak Ali, Carlo Palmieri   +4 more
openalex   +1 more source

A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib. [PDF]

Signal Transduct Target Ther
Shi Y, Lv D, Feng W, Liu S, Xing P, Yu Y, Yin J, Ren X, Zhang J, Han G, Zhang Y, Cang S, Chen J, Chen E, Meng L, Zhang Y.   +15 more
europepmc   +1 more source

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib. [PDF]

In Vivo
Takada S, Umehara K, Watanabe K.
europepmc   +1 more source